When cells were instead treated with exogenous IFN after virus infection, MX1 promoter activity was reduced by rWT VHSV IVb infection compared to IFN treatment alone at 36 or 48 h post infection (Figure 2B). This evidence concerns the gene IFNA1 and viral infectious disease.